title: Re: phase 1 and 2 studies demonstrate the safety and efficacy of intraprostatic injection of PRX302 for the targeted treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia.
authors.forename: Steven A
authors.initials: SA
authors.lastname: Kaplan